US Stock MarketDetailed Quotes
DYN Dyne Therapeutics
- 26.350
- +0.350+1.35%
Trading May 3 14:54 ET
2.27BMarket Cap-6670P/E (TTM)
27.310High26.060Low483.19KVolume26.160Open26.000Pre Close12.93MTurnover0.87%Turnover RatioLossP/E (Static)86.18MShares30.26952wk High24.88P/B1.46BFloat Cap6.40052wk Low--Dividend TTM55.39MShs Float36.570Historical High--Div YieldTTM4.81%Amplitude4.300Historical Low26.751Avg Price1Lot Size
Dyne Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -22.46%-188.16M | -19.92%-35.01M | -18.22%-50.6M | -80.02%-55.64M | 7.55%-46.91M | -28.51%-153.65M | -4.00%-29.19M | -58.82%-42.81M | 33.02%-30.91M | -175.86%-50.74M |
| Net income from continuing operations | -40.36%-235.94M | -71.63%-66.64M | -45.49%-60.21M | -24.09%-64.9M | -24.18%-44.19M | -12.60%-168.1M | 25.02%-38.83M | 2.81%-41.39M | -74.61%-52.3M | -42.51%-35.58M |
| Operating gains losses | 314.71%141K | --0 | --0 | --0 | 370.00%141K | 325.00%34K | --4K | --9K | ---9K | --30K |
| Depreciation and amortization | -0.59%1.67M | -0.50%399K | 8.56%431K | -6.30%431K | -3.06%412K | 54.69%1.68M | 17.60%401K | 52.69%397K | 84.74%460K | 78.57%425K |
| Other non cash items | -52.59%788K | -21.50%168K | 122.59%166K | -78.72%243K | -79.73%211K | 322.79%1.66M | 129.81%214K | -5,553.85%-735K | 14,375.00%1.14M | 14,971.43%1.04M |
| Change In working capital | 589.07%26.31M | 395.13%25.53M | 187.29%4.5M | -74.34%4.2M | 63.57%-7.92M | -158.11%-5.38M | -70.26%5.16M | -146.66%-5.16M | 176.73%16.37M | -1,088.41%-21.75M |
| -Change in prepaid assets | 180.53%3.34M | 707.45%4.12M | -23.96%-4.96M | -62.45%5.57M | 91.02%-1.39M | -175.17%-4.14M | -95.49%510K | -146.61%-4M | 168.22%14.82M | -4,775.83%-15.48M |
| -Change in payables and accrued expense | 1,959.92%22.97M | 360.85%21.41M | 917.29%9.46M | -188.47%-1.37M | -4.20%-6.53M | -109.01%-1.24M | -22.91%4.65M | -123.94%-1.16M | 58.68%1.54M | -435.37%-6.27M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -22.46%-188.16M | -19.92%-35.01M | -18.22%-50.6M | -80.02%-55.64M | 7.55%-46.91M | -28.51%-153.65M | -4.00%-29.19M | -58.82%-42.81M | 33.02%-30.91M | -175.86%-50.74M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -4.46%83.31M | 36.18%26.2M | -75.18%12.82M | -6.57%17.23M | 1,366.95%27.06M | 163.24%87.2M | 8,285.96%19.24M | 1,913.83%51.66M | 386.65%18.44M | 98.34%-2.14M |
| Net PPE purchase and sale | 76.23%-729K | 84.20%-82K | 81.15%-167K | 4.21%-250K | 83.58%-230K | 15.23%-3.07M | 73.92%-519K | -0.57%-886K | 64.63%-261K | -15,466.67%-1.4M |
| Net investment purchase and sale | -6.90%84.04M | 33.01%26.28M | -75.28%12.99M | -6.53%17.48M | 3,813.20%27.29M | 167.23%90.27M | 1,025.70%19.76M | 2,771.28%52.54M | 428.37%18.7M | 99.43%-735K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -4.46%83.31M | 36.18%26.2M | -75.18%12.82M | -6.57%17.23M | 1,366.95%27.06M | 163.24%87.2M | 8,285.96%19.24M | 1,913.83%51.66M | 386.65%18.44M | 98.34%-2.14M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 45.28%54.32M | -99.60%147K | 548.57%454K | 25,057.58%24.91M | 159,983.33%28.82M | -76.31%37.39M | 41,701.12%37.2M | -84.68%70K | 296.00%99K | -99.99%18K |
| Net common stock issuance | 42.07%52.37M | -100.00%-1K | --0 | --24.14M | --28.23M | -76.56%36.86M | --36.86M | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 269.19%1.95M | -56.73%148K | 548.57%454K | 671.72%764K | 3,161.11%587K | -9.42%529K | 284.27%342K | -84.68%70K | 296.00%99K | 38.46%18K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 45.28%54.32M | -99.60%147K | 548.57%454K | 25,057.58%24.91M | 159,983.33%28.82M | -76.31%37.39M | 41,701.12%37.2M | -84.68%70K | 296.00%99K | -99.99%18K |
| Net cash flow | ||||||||||
| Beginning cash position | -14.28%174.47M | -9.93%132.6M | 22.88%169.93M | 21.75%183.44M | -14.28%174.47M | -32.87%203.52M | -36.47%147.22M | -47.03%138.3M | -51.96%150.66M | -32.87%203.52M |
| Current changes in cash | -73.91%-50.53M | -131.79%-8.66M | -518.32%-37.33M | -9.19%-13.5M | 116.97%8.97M | 70.84%-29.05M | 196.58%27.25M | 130.41%8.92M | 76.47%-12.37M | -604.26%-52.86M |
| End cash Position | -28.96%123.94M | -28.96%123.94M | -9.93%132.6M | 22.88%169.93M | 21.75%183.44M | -14.28%174.47M | -14.28%174.47M | -36.47%147.22M | -47.03%138.3M | -51.96%150.66M |
| Free cash flow | -20.53%-188.89M | -18.10%-35.09M | -16.20%-50.77M | -79.31%-55.89M | 9.59%-47.14M | -27.22%-156.71M | 1.15%-29.71M | -56.98%-43.69M | 33.52%-31.17M | -183.34%-52.14M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg